Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”

Authors

Publication Details

Journal
ACS Pharmacology & Translational Science
Published
2026-01-09
DOI
https://doi.org/10.1021/acsptsci.5c00551
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”

Alastair J. King, A. Darragh, Nicole B. Servant, Mirza Jahic et al.
ACS Pharmacology & Translational Science
Chronic Lymphocytic Leukemia Research
article

Correction to “Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures”

Alastair J. King, A. Darragh, Nicole B. Servant, Mirza Jahic, Andrew M. Hanna, Justin Lipner
article en

Abstract

No abstract available for this paper.
ACS Pharmacology & Translational ScienceVol. 9(2)
Zero hunger
Openalex Percentile: Top 93%
Chronic Lymphocytic Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.